News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
768,012 Results
Type
Article (65233)
Company Profile (318)
Press Release (702453)
Multimedia
Podcasts (88)
Webinars (20)
Section
Business (213020)
Career Advice (2393)
Deals (36413)
Drug Delivery (108)
Drug Development (84801)
Employer Resources (179)
FDA (16776)
Job Trends (15614)
News (360136)
Policy (34102)
Tag
Academia (2926)
Academic (1)
Accelerated approval (17)
Adcomms (27)
Allergies (125)
Alliances (52999)
ALS (143)
Alzheimer's disease (1654)
Antibody-drug conjugate (ADC) (250)
Approvals (16881)
Artificial intelligence (459)
Autoimmune disease (105)
Automation (31)
Bankruptcy (367)
Best Places to Work (11981)
BIOSECURE Act (21)
Biosimilars (158)
Biotechnology (200)
Bladder cancer (135)
Brain cancer (49)
Breast cancer (519)
Cancer (4144)
Cardiovascular disease (343)
Career advice (2012)
Career pathing (36)
CAR-T (242)
CDC (46)
Cell therapy (657)
Cervical cancer (32)
Clinical research (70771)
Collaboration (1440)
Company closure (4)
Compensation (975)
Complete response letters (49)
COVID-19 (2877)
CRISPR (86)
C-suite (639)
Cystic fibrosis (137)
Data (5180)
Decentralized trials (2)
Denatured (29)
Depression (112)
Diabetes (447)
Diagnostics (6862)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (210)
Drug pricing (169)
Drug shortages (28)
Duchenne muscular dystrophy (204)
Earnings (90834)
Editorial (56)
Employer branding (22)
Employer resources (158)
Events (120558)
Executive appointments (970)
FDA (19367)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (19)
Funding (1293)
Gene editing (182)
Generative AI (37)
Gene therapy (529)
GLP-1 (932)
Government (4860)
Grass and pollen (7)
Guidances (373)
Healthcare (19660)
HIV (48)
Huntington's disease (37)
IgA nephropathy (71)
Immunology and inflammation (230)
Immuno-oncology (20)
Indications (62)
Infectious disease (3121)
Inflammatory bowel disease (183)
Inflation Reduction Act (13)
Influenza (101)
Intellectual property (198)
Interviews (408)
IPO (16901)
IRA (52)
Job creations (4003)
Job search strategy (1695)
Kidney cancer (15)
Labor market (78)
Layoffs (575)
Leadership (30)
Legal (8230)
Liver cancer (88)
Longevity (13)
Lung cancer (584)
Lymphoma (291)
Machine learning (31)
Management (62)
Manufacturing (630)
MASH (152)
Medical device (13957)
Medtech (13989)
Mergers & acquisitions (20430)
Metabolic disorders (1122)
Multiple sclerosis (141)
NASH (16)
Neurodegenerative disease (223)
Neuropsychiatric disorders (63)
Neuroscience (2704)
NextGen: Class of 2025 (6839)
Non-profit (4865)
Now hiring (59)
Obesity (518)
Opinion (267)
Ovarian cancer (146)
Pain (165)
Pancreatic cancer (184)
Parkinson's disease (239)
Partnered (30)
Patents (423)
Patient recruitment (348)
Peanut (55)
People (61224)
Pharmaceutical (69)
Pharmacy benefit managers (25)
Phase I (22079)
Phase II (31027)
Phase III (23046)
Pipeline (3306)
Policy (274)
Postmarket research (2940)
Preclinical (9973)
Press Release (70)
Prostate cancer (205)
Psychedelics (45)
Radiopharmaceuticals (271)
Rare diseases (662)
Real estate (6508)
Recruiting (71)
Regulatory (24628)
Reports (51)
Research institute (2671)
Resumes & cover letters (395)
Rett syndrome (21)
RNA editing (12)
RSV (73)
Schizophrenia (135)
Series A (210)
Series B (157)
Service/supplier (17)
Sickle cell disease (79)
Special edition (21)
Spinal muscular atrophy (158)
Sponsored (39)
Startups (3860)
State (2)
Stomach cancer (16)
Supply chain (98)
Tariffs (85)
The Weekly (57)
Vaccines (984)
Venture capital (68)
Weight loss (342)
Women's health (64)
Worklife (19)
Date
Today (134)
Last 7 days (730)
Last 30 days (3642)
Last 365 days (31236)
2025 (28147)
2024 (36162)
2023 (41107)
2022 (52385)
2021 (57023)
2020 (55704)
2019 (48519)
2018 (36606)
2017 (33842)
2016 (33881)
2015 (40476)
2014 (34377)
2013 (30567)
2012 (32171)
2011 (32528)
2010 (31142)
Location
Africa (897)
Alabama (78)
Alaska (7)
Arizona (292)
Arkansas (13)
Asia (42611)
Australia (7442)
California (10051)
Canada (2970)
China (929)
Colorado (419)
Connecticut (438)
Delaware (285)
Europe (96110)
Florida (1474)
Georgia (319)
Hawaii (2)
Idaho (62)
Illinois (764)
India (51)
Indiana (472)
Iowa (19)
Japan (340)
Kansas (125)
Kentucky (37)
Louisiana (24)
Maine (70)
Maryland (1299)
Massachusetts (7312)
Michigan (294)
Minnesota (576)
Mississippi (5)
Missouri (117)
Montana (32)
Nebraska (25)
Nevada (107)
New Hampshire (75)
New Jersey (2720)
New Mexico (31)
New York (2692)
North Carolina (1378)
North Dakota (10)
Northern California (4743)
Ohio (299)
Oklahoma (20)
Oregon (39)
Pennsylvania (2072)
Puerto Rico (19)
Rhode Island (43)
South America (1248)
South Carolina (53)
South Dakota (1)
Southern California (3881)
Tennessee (155)
Texas (1552)
United States (36179)
Utah (301)
Virginia (237)
Washington D.C. (82)
Washington State (820)
West Virginia (4)
Wisconsin (91)
Wyoming (2)
768,012 Results for "albany molecular research inc amri".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Novartis Sticks With Monte Rosa in Second Molecular Glue Deal Worth up to $5.7B
Novartis and Monte Rosa first partnered in October 2024 for a molecular glue asset for immune-mediated and autoimmune diseases. This time, the pharma is putting $120 million down upfront for more of the biotech’s AI-discovered degraders.
September 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam Capital Upsized and over-subscribed Series A total funding of $44 million secured Rapafusyn’s RapaGlue™ platform rapidly discovers non-degrading molecular glues, a validated and highly sought-after modality to address challenging disease targets
September 4, 2025
·
1 min read
Press Releases
Arima Genomics Announces Data Presentation at the Association for Molecular Pathology 2025
November 14, 2025
·
2 min read
Press Releases
The Prostate Cancer Foundation and Society of Nuclear Medicine and Molecular Imaging (SNMMI) Collaborate to Advance Prostate Cancer Research
June 25, 2025
·
3 min read
Press Releases
Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy
July 31, 2025
·
7 min read
Press Releases
Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015
November 7, 2025
·
6 min read
Press Releases
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
June 17, 2025
·
8 min read
Press Releases
Psilera Inc. Secures National Institutes of Health Grant for AUD Research
October 3, 2025
·
2 min read
Pharm Country
Albany Molecular Research Inc. (AMRI) to Present at Jefferies 2020 Virtual London Healthcare Conference
Albany Molecular Research, Inc., ( AMRI ), a leading global provider of advanced contract research, development and manufacturing solutions, today announced that its CEO and CFO will present a corporate overview at the Jefferies 2020 Virtual London Healthcare Conference. The presentation, to be delivered by CEO John Ratliff and CFO Jason Knoblauch , will be recorded and made available on AMRI’s website. AMRI’s execu
October 14, 2020
·
1 min read
Press Releases
Fapon to Showcase Innovative Molecular Diagnostic Solutions at AMP 2025 Annual Meeting & Expo
November 10, 2025
·
2 min read
1 of 76,802
Next
